Bird flu vaccine trial against potential pandemic strain begins

• H5N1 vaccine trial launched targeting a potential pandemic strain currently affecting bird populations globally, with no human-to-human transmission documented to date
• Proactive vaccine development aims to prepare healthcare systems for possible future pandemic risk, despite H5N1 remaining primarily a zoonotic threat
• Clinical trial data will inform pandemic preparedness strategy and potential stockpiling decisions for this high-mortality avian influenza strain

The jab targets the H5N1 flu strain which has caused devastating infections in bird populations worldwide, but has yet to spread between humans.

ClinicaliQ summarises and contextualises external updates for clinical awareness, then links to the original publisher for the full article and most current context.